EBV-associated post-transplant lymphoproliferative disorder following in vivo T-cell-depleted allogeneic transplantation: clinical features, viral load correlates and prognostic factors in the rituximab era. (Q42256599)
Jump to navigation
Jump to search
scientific article published on 11 November 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | EBV-associated post-transplant lymphoproliferative disorder following in vivo T-cell-depleted allogeneic transplantation: clinical features, viral load correlates and prognostic factors in the rituximab era. |
scientific article published on 11 November 2013 |
Statements
EBV-associated post-transplant lymphoproliferative disorder following in vivo T-cell-depleted allogeneic transplantation: clinical features, viral load correlates and prognostic factors in the rituximab era (English)
D Burns
K S Peggs
C M Harvey
S Natarajan
D I Marks
B Jackson
G Chakupurakal
M Dennis
Z Lim
G Cook
B Carpenter
A R Pettitt
S Mathew
L Connelly-Smith
J A L Yin
M Viskaduraki
B E Shaw
C Brookes
11 November 2013
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference